Inovio Pharmaceuticals Inc. (INO) Fundamentals

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
SHARE INFORMATION
Market Cap$ 613,525,173
Shares Outstanding249,400,477
Float245,623,265
Percent Float98.49%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,774,757
Latest Fiscal EPS$ -1.45
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions393
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months19,993,399
Institutional Holdings Percent71.2%
Institutional Sold Previous 3 Months18,453,793
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,223,400
Insider Holdings Percent2.7
Insider Sold Previous 3 Months136,600
Insider Shares Owned5,882,410
TRADING INFO
52 Week High$ 9.96
52 Week Low$ 1.38
52 Week High Change$ -71.23
21 Day Moving Average$ 2.1257
21 Day Extended Moving Average$ 2.1723
50 Day Moving Average$ 1.9433
50 Day Extended Moving Average$ 2.1393
200 Day Moving Average$ 3.7531
200 Day Extended Moving Average$ 3.7109
10 Day Average Volume6,706,861
20 Day Average Volume6,378,223
30 Day Average Volume6,123,238
50 Day Average Volume6,428,556
Alpha0.002778
Beta0.8791
Standard Deviation0.253959
R20.029978
7 Day Price Change$ 0.18
7 Day Percent Change7.89%
21 Day Price Change$ 0.36
21 Day Percent Change17.14%
30 Day Price Change$ 0.515
30 Day Percent Change26.48%
Month to Date Price Change$ 0.48
Month to Date Percent Change24.24%
Quarter to Date Price Change$ 0.73
Quarter to Date Percent Change42.2%
180 Day Price Change$ -0.86
180 Day Percent Change-25.9%
200 Day Price Change$ -1.46
200 Day Percent Change-37.24%
Year to Date Price Change$ -2.53
Year to Date Percent Change-50.7%

Inovio Pharmaceuticals Inc. (INO) Key Ratios

PROFITABILITY
EBIT Margin-20,242.5%
EBITDA Margin-19,928.6%
Pre-Tax Profit Margin-3,680.2%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,329,887
Revenue Per Share$ 0.0053
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.90
Total Debt To Equity0.10
Int Coverage-188.00
Current Ratio6.70
Leverage Ratio1.20
Quick Ratio6.20
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio-1.70
Enterprise Value$ 321,694,098
Price to Sales461.3363
Price to Free Cash-4.30
PE High Last 5 Years-4.80
Price To Book1.80
Price To Cash Flow0.00
PE Low Last 5 Years-4.60
Price to Tangible Book1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.10
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-61.72
Return on Equity-72.62
Return on Capital-65.69

Inovio Pharmaceuticals Inc. (INO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJacqueline E. Shea
Emplyoees317
Last AuditUQ
CIK0001055726
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address660 West Germantown Pike
Suite 110
Plymouth Meeting, PA 19462
Websitehttps://www.inovio.com
Facsimile+1 267 440-4242
Telephone+1 267 440-4200
Emailben.matone@inovio.com


Your Recent History
NASDAQ
INO
Inovio Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.